- Home
- BDSX vs AGD Comparison
BDSX vs AGD Comparison
Compare BDSX & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- AGD
- Stock Information
- Founded
- BDSX 2005
- AGD 2006
- Country
- BDSX United States
- AGD United Kingdom
- Employees
- BDSX N/A
- AGD N/A
- Industry
- BDSX Precision Instruments
- AGD Trusts Except Educational Religious and Charitable
- Sector
- BDSX Health Care
- AGD Finance
- Exchange
- BDSX Nasdaq
- AGD Nasdaq
- Market Cap
- BDSX 245.3M
- AGD 253.4M
- IPO Year
- BDSX 2020
- AGD N/A
- Fundamental
- Price
- BDSX $1.69
- AGD $10.51
- Analyst Decision
- BDSX Strong Buy
- AGD
- Analyst Count
- BDSX 4
- AGD 0
- Target Price
- BDSX $3.08
- AGD N/A
- AVG Volume (30 Days)
- BDSX 247.5K
- AGD 61.2K
- Earning Date
- BDSX 11-05-2024
- AGD 01-01-0001
- Dividend Yield
- BDSX N/A
- AGD 8.13%
- EPS Growth
- BDSX N/A
- AGD N/A
- EPS
- BDSX N/A
- AGD N/A
- Revenue
- BDSX $60,902,000.00
- AGD N/A
- Revenue This Year
- BDSX $48.06
- AGD N/A
- Revenue Next Year
- BDSX $29.97
- AGD N/A
- P/E Ratio
- BDSX N/A
- AGD N/A
- Revenue Growth
- BDSX 46.25
- AGD N/A
- 52 Week Low
- BDSX $1.15
- AGD $8.20
- 52 Week High
- BDSX $2.21
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- BDSX 46.06
- AGD 61.10
- Support Level
- BDSX $1.62
- AGD $10.35
- Resistance Level
- BDSX $1.71
- AGD $10.52
- Average True Range (ATR)
- BDSX 0.06
- AGD 0.08
- MACD
- BDSX -0.00
- AGD -0.00
- Stochastic Oscillator
- BDSX 47.62
- AGD 62.16
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.